Evidence map›Paper›PMID 31488891›Full record

ArticleCell death and differentiation2020

Correction to: The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.

Silvia Grasso, Davide Cangelosi, Jennifer Chapelle, Melissa Alzona, Giorgia Centonze, Alessia Lamolinara, Vincenzo Salemme, Costanza Angelini, Alessandro Morellato, Andrea Saglietto and 14 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death and differentiation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 1 country.

Silvia Grasso *Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Davide Cangelosi *Laboratory of Molecular Biology, Giannina Gaslini Institute, 16147, Genova, Italy.
Jennifer Chapelle *Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Melissa Alzona *Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Giorgia CentonzeDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Alessia LamolinaraDepartment of Medicine and Aging Science, Center of Excellence on Aging and Translational Medicine (CeSi-Met), G. D'Annunzio University, Chieti-Pescara, Italy.ORCID http://orcid.org/0000-0002-7421-4509
Vincenzo SalemmeDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Costanza AngeliniDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Alessandro MorellatoDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Andrea SagliettoCardiology Division, Department of Medical Sciences, University of Torino, 10126, Torino, Italy.
Federico Tommaso BianchiDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Sara CabodiDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Iris Chiara SalaroglioDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Federica FusellaDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Marzia OgnibeneLaboratorio Cellule Staminali Post Natali e Terapie Cellulari, Istituto Giannina Gaslini, Genova, Italy.
Manuela IezziDepartment of Medicine and Aging Science, Center of Excellence on Aging and Translational Medicine (CeSi-Met), G. D'Annunzio University, Chieti-Pescara, Italy.ORCID http://orcid.org/0000-0002-6296-6498
Annalisa PezzoloLaboratorio Cellule Staminali Post Natali e Terapie Cellulari, Istituto Giannina Gaslini, Genova, Italy.ORCID http://orcid.org/0000-0001-6321-5701
Valeria PoliDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.ORCID http://orcid.org/0000-0002-3739-3966
Ferdinando Di CuntoNeuroscience Institute Cavalieri Ottolenghi, Regione Gonzole 10, 10043, Orbassano (TO), Italy.ORCID http://orcid.org/0000-0001-9367-6357
Alessandra EvaLaboratory of Molecular Biology, Giannina Gaslini Institute, 16147, Genova, Italy.
Chiara RigantiDepartment of Oncology, University of Torino, 10126, Torino, Italy.ORCID http://orcid.org/0000-0001-9787-4836
Luigi VaresioLaboratory of Molecular Biology, Giannina Gaslini Institute, 16147, Genova, Italy.
Emilia Turco *Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy.
Paola Defilippi *Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Torino, Italy. paola.defilippi@unito.it.ORCID http://orcid.org/0000-0001-6427-4906
University of Turin · ITIstituto Giannina Gaslini · ITNeuroscience Institute · ITUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31488891
PMCPMC7205995
OpenAlexW2972163992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.